ESDPPP – European Society for Developmental Perinatal and Paediatric Pharmacology
ESDPPP is a voluntary, non-profit association representing the interests of paediatric pharmacologists around the world.
REGISTRATION OPEN - Prague Conference 2023
We are delighted to inform, that the registration for the societies next conference is now opened, with an early bird fee until January 15th.
-- EXTENDED EARLY BIRD FEE UNTIL JANUARY 31st --
Pavla Pokorna, our president will host this meeting from 28-30 June 2023 Prague, CZ with a one-day pre-congress workshop on June 27th. The scientific program is nearly finished with exciting topics from gene pharmacotherapy to machine learning and important updates regarding CTs, clinical pharmacology and European networks.
We are already looking forward to the meeting and will do our best to celebrate the
35th ESDPPPP anniversary
in Prague with all of you.
Stay tuned and visit our conference homepage for the latest details and information:
Click here to get registered with the opportunity for active participation with abstract submission:
Webinar on Artificial Intelligence (AI) in Paediatrics
Date: December 7th, 3-6pm (CET)
The webinar is free of charge. Please register yourself by sending an email to conect4childrenwp4@radboudumc.nl.
Speakers:
1) Matthias Schwab – introduction and moderator
2) Jolien Freriksen - Saskia de Wildt - “literature searches and AI”
3) Anke-Hilse Maitland van der Zee - topic “paediatric Asthma and AI”
4) Maaike van der Lee - “AI and drug metabolising enzymes”
5) Wei Zhao - “dose machine learning”
6) Dirk Lanzerath - “AI and ethical considerations”
Young ESDPPP Community
During our last conference in Liverpool, UK a young ESDPPP society emerged. This community of PhD students, postdocs, young researchers and new healthcare professionals cultivates informal, lively, scientific exchanges by monthly online meetings. The focus is set on gaining insights into other PhD projects with fruitful discussions, brainstorming and shared problem-solving. Furthermore, well-founded specialized knowledge is guaranteed by regularly invited speakers.
Young ESDPPP provides a possibility of mutual assistance and novel collaborations in the fields of paediatric pharmacology with the possibility to make joint considerations on how ESDPPP can be strengthened and further developed.
"Give young people a greater voice. They are the future, and they are much wiser than we give them credit for." -Desmond Tuto
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products - Guidance for Industry, FDA
This guidance is intended to assist sponsors of investigational new drug applications and applicants of new drug applications, biologics license applications and supplements to such applications who are planning to conduct clinical studies in neonatal populations.
This guidance provides recommendations for neonatal clinical pharmacology studies and will be useful for education and practice.
Additional tools (graphical snapshot, podcasts) can be found here:
Throwback: Liverpool Conference, June 2023
Our societies 19th Conference, hosted by our president Mark Turner in Liverpool, was a success and wonderful experience - especially to meet in-person again and to have the possibility to gain knowledge on-site after two predominant pandemic years.
Slides, posters and all abstracts will be provided in our "Members Only" area - have a look!
COVID-19
IUPHAR is responding to the current crisis by coordinating pharmacological resources worldwide. Although most of the current research is done in adults, we believe
in part it may be relevant for pediatric pharmacologists as well.
Paediatric Pharmacology
Based in Ghent, Belgium, ESDPPP promotes research in developmental perinatal and paediatric pharmacology and offers a forum for dialogue between pharmacologists, clinicians, and scientists interested in the effect of medicines on the developing fetus, infant, and child.
35 years of ESDPPP
The ESDPPP celebrated its 35th anniversary in 2023. This milestone provides an important opportunity to celebrate ESDPPP’s achievements to date and to describe our future aspirations and ambitions on behalf of millions of paediatric patients worldwide.
Our aim
We aim to improve medicines for children and advance research and global access to paediatric medicines. We also advocate politically for the continued development of safe, evidence-based medications for children. In this respect, ESDPPP works closely with European Medicines Agency (EMA), International Union of Basic and Clinical Pharmacology (IUPHAR) and the World Health Organization (WHO).
Congresses
Meeting our collegues is very important for our society. We enjoyed a wonderful congress in Liverpool, UK, in June 2022 and are looking forward to our next congress, which will be held in Prague (2023). We are welcoming your ideas and suggestions for these events.
Join us on LinkedIn!!
We want to use LinkedIn for announcements and discussions in our field. Please check out our group page on LinkedIn and become a group member.
ADC Journal
The official journal of the ESDPPP is the leading paediatric journal Archives of Disease in Childhood. It contains a Drug Therapy section which is published every 3 months.
Associations
ESDPPP is associated with a range of organizations like EMEA, IUHAR and WHO. Additional information on projects, initiatives and conferences will be available within short.
35 Years ESDPPP
In 2023 ESDPPP celebrated its 35th anniversary at the society's 20th conference in Prague, CZ. The meeting will be hosted by our new president Pavla Pokorna.
After the congress
Our last congress in Liverpool was a great success and a meeting place for many. Did you enjoy it as well? Become a member of ESDPPP and be the first to know more about the next congress in Prague…
Contact information
ESDPPP VZW p/a University Hospital
Gasthuisberg Herestraat 49
B-3000 Leuven
ESDPPP Mission
The primary aim of the society is to promote research in the field of paediatric pharmacology and to offer a forum for exchange between pharmacologists and clinical physicians about more adequate
drug administration.
Join us on LinkedIn